drugset / Trial / NCT00124397

Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)

NCT00124397 ↗

Phase 4 Completed 186 enrolled University of Southern Denmark Pfizer · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study is to examine the effect of intensive cholesterol lowering therapy and tight blood pressure (BP) regulation on endothelial function (inner cell layer of vessels that determines dilatation) in type 2 diabetic patients without documented cardiovascular (CV) disease. The hypothesis is that intensive cholesterol lowering and tight blood pressure regulation will due better than a control group.

Timeline

Start
2001-07
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg —